Cargando…

Letter: Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation (Endocrinol Metab 2014;29:33-9, Eon Ju Jeon et al.)

Detalles Bibliográficos
Autor principal: Jung, Chan-Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091488/
https://www.ncbi.nlm.nih.gov/pubmed/25031895
http://dx.doi.org/10.3803/EnM.2014.29.2.206
_version_ 1782480772371841024
author Jung, Chan-Hee
author_facet Jung, Chan-Hee
author_sort Jung, Chan-Hee
collection PubMed
description
format Online
Article
Text
id pubmed-4091488
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Korean Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-40914882014-07-16 Letter: Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation (Endocrinol Metab 2014;29:33-9, Eon Ju Jeon et al.) Jung, Chan-Hee Endocrinol Metab (Seoul) Letter Korean Endocrine Society 2014-06 2014-06-26 /pmc/articles/PMC4091488/ /pubmed/25031895 http://dx.doi.org/10.3803/EnM.2014.29.2.206 Text en Copyright © 2014 Korean Endocrine Society http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter
Jung, Chan-Hee
Letter: Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation (Endocrinol Metab 2014;29:33-9, Eon Ju Jeon et al.)
title Letter: Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation (Endocrinol Metab 2014;29:33-9, Eon Ju Jeon et al.)
title_full Letter: Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation (Endocrinol Metab 2014;29:33-9, Eon Ju Jeon et al.)
title_fullStr Letter: Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation (Endocrinol Metab 2014;29:33-9, Eon Ju Jeon et al.)
title_full_unstemmed Letter: Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation (Endocrinol Metab 2014;29:33-9, Eon Ju Jeon et al.)
title_short Letter: Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation (Endocrinol Metab 2014;29:33-9, Eon Ju Jeon et al.)
title_sort letter: diagnostic whole-body scan may not be necessary for intermediate-risk patients with differentiated thyroid cancer after low-dose (30 mci) radioactive iodide ablation (endocrinol metab 2014;29:33-9, eon ju jeon et al.)
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091488/
https://www.ncbi.nlm.nih.gov/pubmed/25031895
http://dx.doi.org/10.3803/EnM.2014.29.2.206
work_keys_str_mv AT jungchanhee letterdiagnosticwholebodyscanmaynotbenecessaryforintermediateriskpatientswithdifferentiatedthyroidcancerafterlowdose30mciradioactiveiodideablationendocrinolmetab201429339eonjujeonetal